332 related articles for article (PubMed ID: 18226593)
41. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.
Nabipour I; Larijani B; Vahdat K; Assadi M; Jafari SM; Ahmadi E; Movahed A; Moradhaseli F; Sanjdideh Z; Obeidi N; Amiri Z
Menopause; 2009; 16(5):950-5. PubMed ID: 19387415
[TBL] [Abstract][Full Text] [Related]
42. The association of dietary calcium, bone mineral density and biochemical bone turnover markers in rural Thai women.
Pongchaiyakul C; Kosulwat V; Charoenkiatkul S; Chailurkit LO; Rojroongwasinkul N; Rajatanavin R
J Med Assoc Thai; 2008 Mar; 91(3):295-302. PubMed ID: 18575280
[TBL] [Abstract][Full Text] [Related]
43. Assessment of bone metabolism and mineral density in chronic viral hepatitis.
Yenice N; Gümrah M; Mehtap O; Kozan A; Türkmen S
Turk J Gastroenterol; 2006 Dec; 17(4):260-6. PubMed ID: 17205403
[TBL] [Abstract][Full Text] [Related]
44. The comparative study of bone mineral density between premenopausal women receiving long term suppressive doses of levothyroxine for well-differentiated thyroid cancer with healthy premenopausal women.
Sajjinanont T; Rajchadara S; Sriassawaamorn N; Panichkul S
J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S71-6. PubMed ID: 16858944
[TBL] [Abstract][Full Text] [Related]
45. Cathepsin K predicts femoral neck bone mineral density change in nonosteoporotic peri- and early postmenopausal women.
Prezelj J; Ostanek B; Logar DB; Marc J; Hawa G; Kocjan T
Menopause; 2008; 15(2):369-73. PubMed ID: 17882010
[TBL] [Abstract][Full Text] [Related]
46. The relationship of ghrelin and adiponectin with bone mineral density and bone turnover markers in elderly men.
Gonnelli S; Caffarelli C; Del Santo K; Cadirni A; Guerriero C; Lucani B; Franci B; Nuti R
Calcif Tissue Int; 2008 Jul; 83(1):55-60. PubMed ID: 18563283
[TBL] [Abstract][Full Text] [Related]
47. Depression in premenopausal women: gonadal hormones and serotonergic system assessed by D-fenfluramine challenge test.
Rajewska J; Rybakowski JK
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):705-9. PubMed ID: 12787860
[TBL] [Abstract][Full Text] [Related]
48. Bone mineral density and bone turnover in postmenopausal women treated for breast cancer.
Waltman NL; Ott CD; Twiss JJ; Gross GJ; Lindsey AM; Moore TE
Cancer Nurs; 2008; 31(3):182-90. PubMed ID: 18453874
[TBL] [Abstract][Full Text] [Related]
49. Change in serum undercarboxylated osteocalcin concentration in bilaterally oophorectomized women.
Yasui T; Uemura H; Tomita J; Miyatani Y; Yamada M; Kuwahara A; Matsuzaki T; Maegawa M; Miura M; Irahara M
Maturitas; 2007 Mar; 56(3):288-96. PubMed ID: 17030103
[TBL] [Abstract][Full Text] [Related]
50. [Bone mineral density in premenopausal and postmenopausal women between 50-55 and 50-57 years of age].
Enchev E; Botushanov N; Dzhambazova E
Akush Ginekol (Sofiia); 2007; 46(2):14-7. PubMed ID: 17469445
[TBL] [Abstract][Full Text] [Related]
51. Determinants of bone turnover markers in healthy premenopausal women.
Adami S; Bianchi G; Brandi ML; Giannini S; Ortolani S; DiMunno O; Frediani B; Rossini M;
Calcif Tissue Int; 2008 May; 82(5):341-7. PubMed ID: 18470550
[TBL] [Abstract][Full Text] [Related]
52. [Biochemical markers of age-related changes in bones turnover and bone mineral density in healthy Chinese men].
Jiang YX; Tang SY; Wu XP; Yang LF; Liao EY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):53-6. PubMed ID: 18245905
[TBL] [Abstract][Full Text] [Related]
53. Impact of menopause on lipid and bone metabolism and effect of hormone replacement therapy.
Murano T; Izumi S; Kika G; Haque SF; Okuwaki S; Mori A; Suzuki T; Matsubayashi H; Ikeda M; Goya K; Makino T
Tokai J Exp Clin Med; 2003 Oct; 28(3):109-19. PubMed ID: 15055403
[TBL] [Abstract][Full Text] [Related]
54. Osteoporosis risk in premenopausal women.
Vondracek SF; Hansen LB; McDermott MT
Pharmacotherapy; 2009 Mar; 29(3):305-17. PubMed ID: 19249949
[TBL] [Abstract][Full Text] [Related]
55. Reduced bone mineral density and increased bone turnover in Prader-Willi syndrome compared with controls matched for sex and body mass index--a cross-sectional study.
Vestergaard P; Kristensen K; Bruun JM; Østergaard JR; Heickendorff L; Mosekilde L; Richelsen B
J Pediatr; 2004 May; 144(5):614-9. PubMed ID: 15126995
[TBL] [Abstract][Full Text] [Related]
56. Development and reproducibility of the bone loading history questionnaire.
Dolan SH; Williams DP; Ainsworth BE; Shaw JM
Med Sci Sports Exerc; 2006 Jun; 38(6):1121-31. PubMed ID: 16775555
[TBL] [Abstract][Full Text] [Related]
57. L-thyroxin treatment and post-menopausal osteoporosis: relevance of the risk profile present in clinical history.
La Vignera S; Vicari E; Tumino S; Ciotta L; Condorelli R; Vicari LO; Calogero AE
Minerva Ginecol; 2008 Dec; 60(6):475-84. PubMed ID: 18981975
[TBL] [Abstract][Full Text] [Related]
58. Physical activity and bone turnover markers: a cross-sectional and a longitudinal study.
Adami S; Gatti D; Viapiana O; Fiore CE; Nuti R; Luisetto G; Ponte M; Rossini M;
Calcif Tissue Int; 2008 Dec; 83(6):388-92. PubMed ID: 18949504
[TBL] [Abstract][Full Text] [Related]
59. Disease damage and low bone mineral density: an analysis of women with systemic lupus erythematosus ever and never receiving corticosteroids.
Lee C; Almagor O; Dunlop DD; Manzi S; Spies S; Chadha AB; Ramsey-Goldman R
Rheumatology (Oxford); 2006 Jan; 45(1):53-60. PubMed ID: 16278288
[TBL] [Abstract][Full Text] [Related]
60. Low bone mass in premenopausal women with depression.
Eskandari F; Martinez PE; Torvik S; Phillips TM; Sternberg EM; Mistry S; Ronsaville D; Wesley R; Toomey C; Sebring NG; Reynolds JC; Blackman MR; Calis KA; Gold PW; Cizza G;
Arch Intern Med; 2007 Nov; 167(21):2329-36. PubMed ID: 18039992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
